These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019. Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461 [TBL] [Abstract][Full Text] [Related]
6. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study. Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048 [TBL] [Abstract][Full Text] [Related]
7. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133 [TBL] [Abstract][Full Text] [Related]
8. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test. Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769 [No Abstract] [Full Text] [Related]
9. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis. Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956 [TBL] [Abstract][Full Text] [Related]
10. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Risch M; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Renz H; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch L Biomed Res Int; 2020; 2020():9878453. PubMed ID: 33224987 [TBL] [Abstract][Full Text] [Related]
11. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595 [TBL] [Abstract][Full Text] [Related]
12. Serum IgA, IgM, and IgG responses in COVID-19. Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617 [No Abstract] [Full Text] [Related]
13. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. Beavis KG; Matushek SM; Abeleda APF; Bethel C; Hunt C; Gillen S; Moran A; Tesic V J Clin Virol; 2020 Aug; 129():104468. PubMed ID: 32485620 [TBL] [Abstract][Full Text] [Related]
14. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation. Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180 [TBL] [Abstract][Full Text] [Related]
15. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study. Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945 [TBL] [Abstract][Full Text] [Related]
16. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19. Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840 [TBL] [Abstract][Full Text] [Related]
17. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019. Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737 [TBL] [Abstract][Full Text] [Related]